Vivos Therapeutics (VVOS) Operating Expenses (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Operating Expenses of $9.7 million for Q1 2026, up 78.26% year-over-year from $5.4 million in Q1 2025, and up 3.24% quarter-over-quarter from $9.4 million in Q4 2025.
Vivos Therapeutics (VVOS) Operating Expenses (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Operating Expenses for 7 consecutive years, with $9.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 78.26% year-over-year to $9.7 million; the TTM figure through Mar 2026 stood at $34.7 million (up 74.36% YoY), while the FY2025 annual figure was $30.4 million, up 50.75% from the prior year.
- Operating Expenses improved to $9.7 million in Q1 2026 per VVOS's latest filing, from $9.4 million in the prior quarter.
- Across five years, Operating Expenses topped out at $9.7 million in Q1 2026 and bottomed at $4.6 million in Q2 2024.
- Historically, Operating Expenses has averaged $7.1 million across 5 years, with a median of $7.0 million in 2025.
- Annual changes were most pronounced in 2023 — Operating Expenses sank 31.84% — and 2025, when it soared 91.11%.
- Vivos Therapeutics' Operating Expenses stood at $8.4 million in 2022, then declined by 26.34% to $6.2 million in 2023, then fell by 21.2% to $4.9 million in 2024, then jumped by 91.11% to $9.4 million in 2025, then grew by 3.24% to $9.7 million in 2026.
- Business Quant data shows VVOS's Operating Expenses at $9.7 million in Q1 2026, $9.4 million in Q4 2025, and $8.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 10.90 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 2.84 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 3.59 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 2.67 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 846.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 511.70 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 1.44 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -741.59 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 398.30 Mn |
| 10 | Vivos Therapeutics | 4.93 Mn | 3.13 Mn | 2.95 Mn | 7.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.67 Mn |
| Dec 31, 2025 | 9.37 Mn |
| Sep 30, 2025 | 8.67 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 5.43 Mn |
| Dec 31, 2024 | 4.90 Mn |
| Sep 30, 2024 | 4.98 Mn |
| Jun 30, 2024 | 4.59 Mn |
| Mar 31, 2024 | 5.72 Mn |
| Dec 31, 2023 | 6.22 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 6.62 Mn |
| Mar 31, 2023 | 7.34 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 7.90 Mn |
| Jun 30, 2022 | 9.55 Mn |
| Mar 31, 2022 | 9.19 Mn |
| Dec 31, 2021 | 10.52 Mn |
| Sep 30, 2021 | 8.69 Mn |
| Jun 30, 2021 | 7.69 Mn |